Pelthos Therapeutics Inc. - Common Stock, par value $0.0001 per share (CHRO)

CUSIP: 171126105

Q1 2024 13F Holders as of 31 Mar 2024

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
6,039,027
Total 13F shares
251,888
Share change
+251,888
Total reported value
$659,947
Price per share
$2.62
Number of holders
1
Value change
+$659,947
Number of buys
1

Quarterly Holders Quick Answers

What is CUSIP 171126105?
CUSIP 171126105 identifies CHRO - Pelthos Therapeutics Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Pelthos Therapeutics Inc. - Common Stock, par value $0.0001 per share (CHRO) as of Q1 2024

As of 31 Mar 2024, Pelthos Therapeutics Inc. - Common Stock, par value $0.0001 per share (CHRO) was held by 1 institutional shareholder that filed Form 13F with the SEC. Together, they reported ownership of 251,888 shares. The largest 1 holders included Anson Funds Management LP. This page lists 1 institutional shareholders reporting positions in this security for the Q1 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.